A pilot study assessing patterns of response or resistance to preoperative dose dense docetaxel in women with newly diagnosed breast cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Docetaxel (Primary) ; Pegfilgrastim
- Indications Breast cancer
- Focus Therapeutic Use
- 04 Nov 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2016.
- 11 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016.
- 18 Mar 2013 Planned end date changed from 1 Jan 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.